Civica Rx

From WikiMD's WELLNESSPEDIA

An overview of Civica Rx, a non-profit pharmaceutical company


Civica Rx is a non-profit pharmaceutical company that was established to address the issue of drug shortages and high prices in the United States. The company was founded in 2018 by a consortium of hospitals and health systems, with the goal of ensuring a stable supply of essential generic medications.

History[edit]

Civica Rx was founded in 2018 in response to the growing problem of drug shortages in the United States. The company was initiated by a group of health systems and philanthropies, including the Mayo Clinic, Intermountain Healthcare, and the Laura and John Arnold Foundation. The founding members aimed to create a new model for the production and distribution of generic drugs, focusing on transparency and sustainability.

Mission and Goals[edit]

The primary mission of Civica Rx is to reduce drug shortages and lower the cost of generic medications. The company aims to achieve this by:

  • Producing essential generic drugs that are in short supply.
  • Offering these drugs at a fair and sustainable price.
  • Ensuring a reliable supply chain to prevent future shortages.

Operations[edit]

Civica Rx operates by partnering with contract manufacturers to produce generic drugs. The company focuses on medications that are critical for patient care and have been subject to shortages. By working directly with hospitals and health systems, Civica Rx ensures that its products are distributed efficiently and reach the patients who need them most.

Products[edit]

Civica Rx produces a range of generic medications, including antibiotics, anesthetics, and other essential hospital drugs. The company prioritizes drugs that are frequently in short supply and are vital for patient care.

Impact[edit]

Since its inception, Civica Rx has had a significant impact on the availability and pricing of generic drugs in the United States. By providing a stable supply of essential medications, the company has helped to alleviate drug shortages and reduce costs for hospitals and patients.

Future Plans[edit]

Civica Rx plans to expand its product line and increase its manufacturing capabilities. The company is also exploring partnerships with additional health systems and manufacturers to further its mission of ensuring a reliable supply of affordable generic drugs.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.